Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Study shows AI can be safely deployed in NHS prostate cancer diagnosis

Findings from the landmark Articulate Pro study have now been published, marking a major milestone for the use of artificial intelligence (AI) in NHS histopathology laboratories and demonstrating its potential to improve and standardise prostate cancer diagnosis.

Professor Clare Verrill using the AI pathology software © Nuffield Department of Surgical Sciences

Led by Professor Clare Verrill at the University of Oxford’s Nuffield Department of Surgical Sciences, the study is one of the first examples of real time use of AI technology in NHS histopathology practice. It provides new evidence that AI can be safely and effectively incorporated within routine diagnostic workflows.

The technology, Paige Prostate, was evaluated in the prostate cancer biopsy pathway across three NHS trusts in the UK. The aim was to assess whether the AI diagnostic system could support more consistent and accurate diagnosis.

The Paige Prostate Suite is a group of AI-powered applications designed to aid in the detection and grading of prostate cancer on routine stained images of prostate needle biopsies. The study examined how using the Paige Prostate Suite impacted pathologists’ clinical decision-making, pathology service delivery, and use of resources in real-world NHS setting.

The study - called ‘Articulate Pro: Artificial Intelligence for Cellular Pathology Transformation in Prostate Practice’ - was delivered by a multi-disciplinary team, and the technology was rolled out for evaluation at Oxford University Hospitals NHS Foundation Trust, North Bristol NHS Trust, and University Hospitals Coventry and Warwickshire NHS Trust.

Read the full story on the University of Oxford website

Similar stories

Exceptional early-career researchers awarded 2026 European Research Council Starting Grants

Four University of Oxford researchers have been awarded prestigious European Research Council (ERC) Starting Grants, each worth €1.5 million for a period of up to five year

How body fat is stored across organs may reveal hidden health risks, study suggests

Researchers from the Nuffield Department of Population Health and the University of Oxford’s Big Data Institute have contributed to a new study showing that how fat accumulates in the body is just as important for identifying different health risks as a person’s overall weight.

Four Oxford researchers recognised in the 2026 Royal Society Awards

The annual Royal Society Awards recognise outstanding contributions to scientific discovery, public engagement and research culture. Of the 27 awards for 2025-26, announced today, four honour Oxford University researchers.

New shingles vaccine linked to lower risk of coronary heart disease, stroke and heart failure – major study indicates

The shingles vaccine currently in use, called ‘Shingrix’, is associated with a reduced risk of cardiovascular events – including heart attacks, heart failure and stroke – compared to the previous shingles vaccine, according to a major new study published in Nature Medicine.

Vapes help more people quit smoking than other methods, Oxford-led Cochrane review finds

An updated Cochrane review led by Oxford researchers finds nicotine e-cigarettes help more people quit smoking than nicotine patches and gum, behavioural support or no support. The living review now includes 80 trials and nearly 30,000 participants.

Brain imaging study reveals how we decide whether we are in control

A brain imaging and stimulation study led by the University of Oxford has identified the brain mechanisms that help us work out whether the consequences we experience are caused by our own actions or by circumstances beyond our control.